Compass Therapeutics, Inc. (CMPX) SEC Filings — 2025
9 SEC filings for Compass Therapeutics, Inc. (CMPX) in 2025.
Filings
- Compass Therapeutics' Net Loss Widens Amid R&D Surge, Bolstered by Equity Raise — 10-Q · Nov 5, 2025
- Compass Therapeutics Files 8-K: Material Agreement & Other Events — 8-K · Aug 13, 2025
- Compass Therapeutics Burns Cash on R&D, No Revenue in Q2 — 10-Q · Aug 11, 2025
- Compass Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Jun 12, 2025
- Compass Therapeutics Files Q1 2025 10-Q — 10-Q · May 8, 2025
- Compass Therapeutics Files Definitive Proxy Statement — DEF 14A · Apr 29, 2025
- Compass Therapeutics Files 8-K — 8-K · Apr 1, 2025
- Compass Therapeutics Files 2024 10-K — 10-K · Feb 27, 2025
- Compass Therapeutics Files 8-K — 8-K · Jan 8, 2025